Skip Navigation


Carcinogenesis Advance Access originally published online on January 12, 2008
Carcinogenesis 2008 29(3):579-584; doi:10.1093/carcin/bgm304
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/3/579    most recent
bgm304v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Landi, D.
Right arrow Articles by Landi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landi, D.
Right arrow Articles by Landi, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer

Debora Landi1,2, Federica Gemignani1, Alessio Naccarati3, Barbara Pardini3, Pavel Vodicka3, Ludmila Vodickova3,4, Jan Novotny5,6, Asta Försti2,7, Kari Hemminki2,7, Federico Canzian2 and Stefano Landi1,*

1 Dipartimento di Biologia, University of Pisa, Via Derna, 1, 56126 Pisa, Italy
2 Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
3 Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Science of Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic
4 Centre of Occupational Health, National Institute of Public Health, Srobarova, 100 42 Prague 10, Czech Republic
5 Department of Oncology, First Faculty of Medicine, Charles University, 12000 Prague, Czech Republic
6 Oncology Centre, Hospital 26205 Pribram, Pribram, Czech Republic
7 Center for Family and Community Medicine, Karolinska Institute, SE-17177 Huddinge, Sweden

* To whom correspondence should be addressed. Tel: +39 050 2211505; Fax: +39 0502211527;Email: slandi{at}biologia.unipi.it

Recent evidence indicate that small non-coding RNA molecules, called micro-RNAs (miRNAs), can bind to the 3' untranslated regions (UTRs) of messenger RNAs and interfere with their translation, thereby regulating cell growth, differentiation, apoptosis and tumorigenesis. Genetic polymorphisms can reside on miRNA-binding sites. Thus, it is conceivable that the miRNA regulation may be affected by polymorphisms on the 3' UTRs. Since gene deregulation is one of the key mechanisms by which cells can progress to cancer, we hypothesize that common polymorphisms within miRNA-target binding sites could play a role in the individual risk of cancer. In the present study, we selected the 3' UTRs of 104 genes candidate for colorectal cancer (CRC) and we identified putative miRNA-binding sites by specialized algorithms (PicTar, DianaMicroT, miRBase, miRanda, TargetScan and microInspector). Fifty-seven single-nucleotide polymorphisms (SNPs) were identified in miRNA-binding sites. We evaluated the SNPs for their ability to affect the binding of the miRNA with its target, by assessing the variation of Gibbs free energy between the two alleles of each SNP. We found eight common polymorphisms that were further investigated by a case–control association studies. The study was carried out on a series of cases and controls from Czech Republic, a population with the highest worldwide incidence of CRC. We found statistically significant associations between risk of CRC and variant alleles of CD86 [odds ratio (OR) = 2.74; 95% confidence interval (CI) = 1.24–6.04, for the variant homozygotes] and INSR genes (OR = 1.94; 95% CI = 1.03–3.66, for the variant homozygotes). These results are the first reporting positive association between miRNA-binding SNPs sequences and cancer risk.

Abbreviations: CRC, colorectal cancer; CI, confidence interval; mRNA, messenger RNA; miRNA, micro-RNA; MAF, minor allele frequency; nt, nucleotide; OR, odds ratio; SNP, single-nucleotide polymorphism; UTR, untranslated region

Received October 24, 2007; revised December 6, 2007; accepted December 22, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. Hiard, C. Charlier, W. Coppieters, M. Georges, and D. Baurain
Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates
Nucleic Acids Res., November 11, 2009; (2009) gkp926v1.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Paranjape, F J Slack, and J B Weidhaas
MicroRNAs: tools for cancer diagnostics
Gut, November 1, 2009; 58(11): 1546 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Song, H. Zheng, B. Liu, S. Wei, H. Dai, L. Zhang, G. A. Calin, X. Hao, Q. Wei, W. Zhang, et al.
An miR-502-Binding Site Single-Nucleotide Polymorphism in the 3'-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset
Clin. Cancer Res., October 1, 2009; 15(19): 6292 - 6300.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Saetrom, J. Biesinger, S. M. Li, D. Smith, L. F. Thomas, K. Majzoub, G. E. Rivas, J. Alluin, J. J. Rossi, T. G. Krontiris, et al.
A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis
Cancer Res., September 15, 2009; 69(18): 7459 - 7465.
[Abstract] [Full Text] [PDF]


Home page
Cancer Genomics ProteomicsHome page
N. VALERI, C. M. CROCE, and M. FABBRI
Pathogenetic and Clinical Relevance of MicroRNAs in Colorectal Cancer
Cancer Genomics Proteomics, July 1, 2009; 6(4): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Kato, L. Arce, and R. Natarajan
MicroRNAs and Their Role in Progressive Kidney Diseases
Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1255 - 1266.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. Savas and G. Liu
Studying Genetic Variations in Cancer Prognosis (and Risk): A Primer for Clinicians
Oncologist, July 1, 2009; 14(7): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Fabbri, N. Valeri, and G. A. Calin
MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift
Carcinogenesis, June 1, 2009; 30(6): 912 - 917.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Tian, Y. Shu, J. Chen, Z. Hu, L. Xu, G. Jin, J. Liang, P. Liu, X. Zhou, R. Miao, et al.
A Functional Genetic Variant in microRNA-196a2 Is Associated with Increased Susceptibility of Lung Cancer in Chinese
Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1183 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M. W. Pfaffl, G. L. Shipley, et al.
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Clin. Chem., April 1, 2009; 55(4): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Tchatchou, A. Jung, K. Hemminki, C. Sutter, B. Wappenschmidt, P. Bugert, B. H.F. Weber, D. Niederacher, N. Arnold, R. Varon-Mateeva, et al.
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women
Carcinogenesis, January 1, 2009; 30(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Chen, F. Song, G. A. Calin, Q. Wei, X. Hao, and W. Zhang
Polymorphisms in microRNA targets: a gold mine for molecular epidemiology
Carcinogenesis, July 1, 2008; 29(7): 1306 - 1311.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.